Articles tagged with:

View all tags

Our Community

Polio Australia - support of polio retreat to help those affected

Polio is a disease that has virtually been forgotten by our community. Although vaccination implemented in Australia in the late 1950s has prevented new infections, polio survivors form the largest single physical disability group in the country.

How we do business

Fostering excellence in respiratory research

GSK has been a significant supporter of The George Institute for Global Health for a number of years and we’ve recently contributed $161,000 to support a research fellow in respiratory medicine.

How we do business

Crowd sourcing new treatments for malaria

New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.

Access to healthcare

Increasing medicine access across the world's poorest nations

GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

How we do business

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

How we do business

Open source: the future of medical discovery

There is growing recognition that no single research body or group has the know-how or resources to tackle the most widespread and persistent diseases. Fortunately, a growing number of scientists are engaged in open source innovation that removes barriers and creates a more transparent environment for medical discovery.

How we do business

PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines

The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.

Our Community

Employees helping communities

Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.

Back to top